Mechanisms of ligand binding and efficacy at the human D2(short) dopamine receptor

Journal of Neurochemistry

Volumn 82, Issue 5, 2002, Pages 1106-1117

  Payne, Sarah L ^a   Johansson, Anette M ^b   Strange, Philip G ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

35S GTP S binding; Adenylyl cyclase; D2 dopamine receptor; G protein activation; Mechanism of action

Indexed keywords

ADENYLATE CYCLASE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; LIGAND; PHENETHYLAMINE DERIVATIVE; SPIPERONE; TETRALIN DERIVATIVE;

ANIMAL CELL; ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HUMAN; LIGAND BINDING; MODEL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CYCLIC AMP; DOPAMINE AGONISTS; FORSKOLIN; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; LIGANDS; PHENETHYLAMINES; RECEPTORS, DOPAMINE D2; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; TETRAHYDRONAPHTHALENES;

ANIMALIA;

EID: 0036724784     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01046.x     Document Type: Article

References (35)

1. Receptor-effector coupling by G-proteins
2. Operational models of pharmacological agonism
3. 1B adrenergic receptor involved in agonist binding: Differences in docking catecholamines to receptor subtypes
4. The effect of multiple serine/alanine mutations in TMV of the D2 dopamine receptor
5. Binding, gating and efficacy: The interpretation of structure-activity relationships for agonists and of the effects of mutating receptors
6. 2 receptors
7. A ternary complex model explains the agonist specific binding properties of the adenylyl cyclase-coupled β-adrenergic receptor
8. Guanine nucleotide regulation of agonist binding to muscarinic acetylcholine receptors
9. High affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5HT2a and 5HT2c receptors: Evidence favouring the ternary complex and two state models of agonist action
10. Agonist action at D2 (long) dopamine receptors: Ligand binding and functional assays
11. 2long dopamine receptors expressed in recombinant cells
12. 2(short) dopamine receptors determined in ligand binding and functional assays
13. 2(444) receptor and antagonist/agonist binding ratios
14. s
15. 2B subtypes in a heterologous cell line
16. 1-adrenergic receptor agonist binding and activation
17. 2 guanine nucleotide binding protein coupled receptor. Utilisation of receptor state binding affinities
18. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins
19. 2 adrenergic receptor
20. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors
21. Interactions of ligands with active and inactive conformations of the dopamine D2 receptor
22. 2 receptor
23. A highly sensitive adenylate cyclase assay
24. 2-adrenergic receptor
25. 2 receptor binding sites for agonists. A tetrahedral model
26. Interaction of ergot alkaloids with anterior pituitary D2 dopamine receptors
27. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor
28. The energetics of ligand binding to catecholamine receptors
29. 7TM receptors: Locks and keys
30. G-protein coupled receptors - Conformations and states
31. Deletion analysis of the m4 muscarinic receptor. Molecular determinants for activation of but not coupling to guanine nucleotide binding regulatory protein regulate receptor internalisation
32. 2a-adrenergic receptors: Identification of amino acids involved in ligand binding and receptor activation by agonists
33. The cubic ternary complex receptor occupancy model
34. 2 dopamine receptor: Use of a mutant receptor that adopts the activated conformation
35. 2 dopamine receptor of the anterior pituitary gland